TNF-α contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 272, Issue 4 35-4, 1997, Pages

  Ferraz, José Geraldo P ^a   Tigley, Allan W ^a   Appleyard, Caroline B ^a   Wallace, John L ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

cirrhosis; portal hypertension; stomach; tumor necrosis factor

Indexed keywords

ALCOHOL; DEXAMETHASONE; MESSENGER RNA; PENTOXIFYLLINE; PROSTAGLANDIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; HYPEREMIA; LIVER CIRRHOSIS; MALE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RAT; STOMACH BLOOD FLOW; STOMACH MUCOSA INJURY;

EID: 0030989265     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.272.4.g809     Document Type: Article

References (33)

1. Appleyard, C. B., D.-M. McCafferty, A. W. Tigley, M. G. Swain, and J. L. Wallace. Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am. J. Physiol. 270 (Gastrointest. Liver Physiol. 33): G42-G48, 1996.
2. Arakawa, T., H. Satoh, T. Fukuda, H. Nakamura, and K. Kobayashi. Endogenous prostaglandin E2 in gastric mucosa of patients with alcoholic cirrhosis and portal hypertension. Gastroenterology 93: 135-140, 1987.
3. Beck, P. L., S. S. Lee, G. W. McKnight, and J. L. Wallace. Characterization of spontaneous and ethanol-induced gastric damage in cirrhotic rats. Gastroenterology 103: 1048-1055, 1992.
4. 1 administration in cirrhotic rats. Gastroenterology 105: 1483-1489, 1993.
5. Beck, P. L., W. McKnight, S. S. Lee, and J. L. Wallace. Prostaglandin modulation of gastric blood flow and mucosal integrity in cirrhotic rats. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G453-G458, 1993.
6. Beyaert, R., and W. Fiers. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett. 340: 9-16, 1994.
7. Casadevall, M., J. Panes, J. M. Piqué, N. Marroni, J. Bosch, and B. J. R. Whittle. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anesthetized rats. Hepatology 18: 628-634, 1993.
8. Chensue, S. W., D. G. Remick, C. Shmyr-Forsch, T. F. Beals, and S. L. Kunkel. Immunochemical demonstration of cytoplasmic and membrane associated tumor necrosis in murine macrophages. Am. J. Pathol. 133: 564-572, 1988.
9. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. Cooper, A. L., S. Brouwer, A. V. Turnbull, G. N. Luheshi, S. J. Hopkins, S. L. Kunkel, and N. J. Rothwell. Tumor necrosis factor-α and fever after peripheral inflammation in the rat. Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R1431-R1436, 1994.
11. Edwards, M. J., D. L. Abney, and F. N. Miller. Pentoxifylline inhibits interleukin-2-induced leukocyte-endothelial adherence and reduces systemic toxicity. Surgery 110: 199-204, 1991.
12. Ferraz, J. G. P., G. W. McKnight, K. A. Sharkey, and J. L. Wallace. Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. Gastroenterology 108: 1183-1191, 1995.
13. Ferraz, J. G. P., and J. L. Wallace. Prostaglandins modulate the responsiveness of the gastric microcirculation to sodium nitroprusside in cirrhotic rats. Hepatology 23: 123-129, 1996.
14. Foley, K. P., M. W. Leonard, and J. D. Engel. Quantitation of RNA using the polymerase chain reaction. Trends Genet. 9: 380-385, 1993.
15. Gostout, C. J., T. R. Viggiano, and B. K. Balm. Acute gastrointestinal bleeding from portal hypertensive gastropathy: prevalence and clinical features. Am. J. Gastroenterol. 88: 2030-2033, 1993.
16. Hansen, P. R. In vitro studies on responses to pentoxifylline and aminophylline on rat mesenteric resistance vessels. Eur. J. Pharmacol. 261: 105-110, 1994.
17. Ichikawa, Y. A. Tarnawski, I. J. Sarfeh, T. Ishikawa, and H. Shimada. Distorted microangioarchitecture and impaired angiogenesis in gastric mucosa of portal hypertensive rats. Gastroenterology 106: 702-708, 1994.
18. Iwao, T., A. Toyonaga, M. Sumino, K. Takagi, K. Oho, M. Nishizono, K. Ohkubo, R. Inoue, E. Sasaki, and K. Tanikawa. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 102: 2060-2065, 1992.
19. Kirisits, M. J., D. Vardimon, H. W. Kunz, and T. J. Gill III. Mapping of the TNF-α locus in the rat. Immunogenetics 39: 59-60, 1994.
20. Kunkel, S. L., R. C. Wiggins, S. W. Chensue, and J. Larrick. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 137: 404-410, 1986.
21. Kvietys, P. R., B. Twohig, J. Danzell, and R. D. Specian. Ethanol-induced injury to the rat gastric mucosa. Role of neutrophils and xanthine oxidase-derived radicals. Gastroenterology 98: 909-920, 1990.
22. Lopez-Talavera, J. C., W. W. Merill, and R. J. Groszmann. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal hypertensive rats. Gastroenterology 108: 761-767, 1995.
23. McCormack, T. T., J. Sims, I. Eyre-Brook, H. Kennedy, J. Goepel, A. G. Johnson, and D. R. Triger. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 26: 1226-1232, 1985.
24. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63, 1983.
25. Murch, S. H., C. P. Braegger, J. A. Walker-Smith, and T. T. McDonald. Location of tumor necrosis factor-α by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705-1709, 1993
26. Murch, S. H., V. A. Lamkin, M. O. Savage, J. A. Walker-Smith, and T. T. McDonald. Serum concentrations of tumor necrosis factor-α in childhood chronic inflammatory bowel disease. Gut 32: 913-917, 1991.
27. Nishizaki, Y., P. H. Guth, C. Sternini, and J. D. Kaunitz. Impairment of the gastric hyperemic response to luminal acid in cirrhotic rats. Am. J. Physiol. 270 (Gastrointest. Liver Physiol. 33): G71-G78, 1996.
28. Nishizaki, Y., J. Kaunitz, M. Oda, and P. H. Guth. Impairment of gastric mucosal defenses measured in vivo in cirrhotic rats. Hepatology 20: 445-452, 1994.
29. Orloff, M. J., M. S. Orloff, S. L. Orloff, K. S. Haynes. Treatment of bleeding from portal hypertensive gastropathy by portocaval shunt. Hepatology 21: 1011-1017, 1995.
30. Peterson, T. C. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 17: 486-493, 1993.
31. Quintero, E., J. M. Piqué, J. A. Bomhi, J. M. Bordas, J. Sentis, M. Elena, J. Bosch, and J. Rodés. Gastric mucosal vascular ectasias causing bleeding in cirrhosis: a distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology 93: 1054-1061, 1987.
32. Santucci, L., S. Fiorucci, M. Giansanti, F. M. Di Matteo, and A. Morelli. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumor necrosis factor alpha. Gut 35: 909-915, 1984.
33. Wong, H., W. D. Anderson, T. Cheng, and K. T. Riabowol. Monitoring mRNA expression by polymerase chain reaction: the "primer-dropping" method. Anal. Biochem. 223: 251-258, 1994.